Skip to main content
Caplight Logo









Form Bio

Form Bio

Private
Austin, TexasHealthcare & Life Scienceshttps://www.formbio.com/

Last Round

Series A

Sep 27, 2022

Total Funding Raised

$30M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Form Bio is a biotechnology company that develops artificial intelligence-powered tools to enhance AAV gene therapy development through predictive modeling, automated candidate optimization, and virtual biomanufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

gene therapyAAVadeno-associated viruscomputational biologybioinformaticsdrug discoveryin silico drug discoverypredictive modelingvector optimizationbiotech softwareAI drug discoverydigital biologymanufacturing intelligencevertical SaaSlab-to-cloud

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Form Bio Comparables

Compare Form Bio with similar companies based on industry and business-model similarity.

Form Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LatchBio
78%
Watershed
74%
Betteromics
74%

Form Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 27, 2022

Key People

Founding team and executive leadership

Andrew Busey

Co-founder Co-CEO

Founding Team

Douglas Daniels

Chief Technology Officer

Executive Team

Linda Murray

Chief Financial Officer

Executive Team

Form Bio Investors

Notable investors and investment history

Form Bio investors
InvestorRounds
JAZZ Venture PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 9, 2026

    Secured a multi-million dollar annual software services contract.

  • Aug 18, 2025

    Michelle Chen appointed President, CEO, and Board member.

Form Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Form Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Form Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range41
Year Founded2022
Last FundingSep 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?